Until Aperiomics’ service was launched, detection of pathogens that cause infection was a hit-and-miss process that left patients and clinicians frustrated. Too often, people were sick for months or years before their clinicians could make accurate diagnoses and begin the healing process. This was highly challenging for medical professionals and often heartbreaking for patients and their families. More than 75% of infections in the U.S. go undetected and millions of dollars are spent each year by patients on testing that too often completely fails patients.
Aperiomics has set out to change that. Today, with a single test using deep, unbiased sequencing and genomic analysis approaches, we can identify any known pathogen. We compare the complete genetic fingerprint of a sample to our own database of more than 32k+ microbes/pathogens, the largest database of its kind in the world.
Aperiomics is upending everything about the way in which infections are identified, completely changing the thinking about pathogen testing. Armed with brilliant ideas to fill a huge gap in medical testing and a mission to help those in need, the company launched in 2014.